AddLife : acute;s Annual Report for 2023 is now published
April 05, 2024 at 09:50 am EDT
Share
English
Published: 2024-04-05 15:45:00 CEST
AddLife AB
Annual Financial Report
AddLife´s Annual Report for 2023 is now published
AddLife´s Annual Report for 2023 is now available online at the company website. The Annual Report can be downloaded in pdf version.
Visithttps://reports-en.add.life/annual-report-2023/addlife-2023/
Stockholm, April 5, 2024
AddLife AB (publ)
AddLife AB, Box 3145, 103 62 Stockholm
Tel +46 (0)8-420 038 30
www.add.life
info@add.life
For further information, please contact:
Fredrik Dalborg, VD, fredrik.dalborg@add.life, +46 70 516 09 01
Christina Rubenhag, CFO, christina.rubenhag@add.life, +46 70 546 72 22
AddLife is an independent European player in Life Science that offers high-quality products, services and consulting to both the private and public sectors. AddLife has about 2,300 employees in around 85 operating subsidiaries, which operate under their own brands. The Group has annual sales of SEK 9.7 billion 2023. AddLife is listed on the NASDAQ Stockholm stock exchange.
The information in this press release is of the nature that AddLife AB (publ) is obliged to make public pursuant to Nasdaq Stockholm rulebook for issuers. The information was submitted for publication, through the agency of the contact persons set out above, on April 5, 2024 at 15.45 (CET).
Attachments:
04057000.pdf
This news release was distributed by Company News System, www.nasdaqomxnordic.com/news/marketnotices
To subscribe on regulatory news from this company, go to the subscription page
Attachments
Original Link
Permalink
Disclaimer
AddLife AB published this content on
05 April 2024 and is solely responsible for the information contained therein. Distributed by
Public, unedited and unaltered, on
05 April 2024 13:49:07 UTC.
AddLife AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company markets and sells instruments, equipment, consumables and related services mainly to the healthcare sector. The Company operates through two segments: The LabTech segment is engaged in the sales of laboratory equipment, analytical instruments and reagents, that are used for diagnostics or biomedical research; The MedTech segment offers various medical device equipment, consumables, instruments and devices, primarily to hospitals. The Company operates through number of subsidiaries, such as BergmanLabora AB, BioNordica group, Holm & Halby A/S, Immuno Diagnostic Oy, LabRobot Products AB, Triolab-group, Active Care Sverup AB, Fenno Medical Oy, Mediplast AB, among others.
ADDLIFE AB 
